0.92
1.88%
0.017
Promis Neurosciences Inc Stock (PMN) Forecast
The Promis Neurosciences Inc (PMN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $2.1857, representing a +137.58% increase from the current price of $0.92. The highest analyst price target is $2.6757, and the lowest is $1.6958.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PMN Price Target
Average 2.1547
(+134.21% Upside)
Is Promis Neurosciences Inc (PMN) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 45.02 | Neutral |
STOCH(9,6) | 17.92 | Buy |
STOCHRSI(14) | 42.38 | Neutral |
MACD(12,26) | -0.0264 | Sell |
ADX(14) | 10.25 | Neutral |
William %R | -68.75 | Neutral |
CCI(14) | -62.67 | Neutral |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
0.9331
Sell
|
0.9227
Sell
|
MA20 |
0.9371
Sell
|
0.9413
Sell
|
MA50 |
0.9884
Sell
|
1.0107
Sell
|
MA100 |
1.1195
Sell
|
1.1544
Sell
|
MA200 |
1.5058
Sell
|
1.3515
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, PMN could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 11 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PMN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 45.02 indicates that PMN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.92 indicates that PMN is oversold. This indicates that PMN price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 42.38 indicates that PMN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 10.25 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -62.67 indicates that PMN is still oversold but not to an extreme extent.
Long-term PMN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Promis Neurosciences Inc financial reports and earnings history, Promis Neurosciences Inc (PMN) stock could reach $2.0855 by 2030, $4.3844 by 2040 and $5.3084 by 2050. See the projected annual prices until 2050 of the Promis Neurosciences Inc stock below:
- Promis Neurosciences Inc (PMN) is expected to reach an average price of $2.812 in 2035, with a high prediction of $3.3208 and a low estimate of $2.3232. This indicates an $205.65% rise from the last recorded price of $0.92.
- Promis Neurosciences Inc (PMN) stock is projected to chart a bullish course in 2040, with an average price target of $3.9428, representing an $328.57% surge from its current level. The forecast ranges from a conservative $2.3105 to a sky-high $4.3844.
- Our analysts predict Promis Neurosciences Inc (PMN) to jump 310.65% by 2045, soaring from $3.1804 to an average price of $3.7779, potentially reaching $3.8879. While $3.1804 is the low estimate, the potential upside is significant.
- Promis Neurosciences Inc (PMN) stock is expected to climb by 2050, reaching an average of $4.2215, a $358.86% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.3084 and $3.3705, respectively, highlighting the market's uncertainty.
Promis Neurosciences Inc Stock (PMN) Year by Year Forecast
Promis Neurosciences Inc Stock (PMN) Price Forecast for 2025
Promis Neurosciences Inc Stock (PMN) is expected to reach an average price of $2.1547 in 2025, with a high prediction of $3.2299 and a low estimate of $1.0796. This indicates an +134.21% rise from the last recorded price of $0.92.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $2.069 | $1.6958 | $2.6757 | +124.89% |
February, 2025 | $2.1378 | $1.4659 | $2.5278 | +132.37% |
March, 2025 | $1.8683 | $1.8383 | $2.2481 | +103.07% |
April, 2025 | $1.4788 | $1.4313 | $2.2116 | +60.74% |
May, 2025 | $1.2792 | $1.1892 | $1.6289 | +39.05% |
June, 2025 | $1.5237 | $1.0796 | $1.6965 | +65.62% |
July, 2025 | $2.2002 | $1.4599 | $3.2299 | +139.16% |
August, 2025 | $2.2207 | $1.5905 | $2.4799 | +141.38% |
September, 2025 | $2.1111 | $1.9359 | $2.3309 | +129.47% |
October, 2025 | $2.1117 | $1.7615 | $2.7414 | +129.53% |
November, 2025 | $2.1816 | $1.5319 | $2.2916 | +137.13% |
December, 2025 | $1.9324 | $1.9024 | $2.5917 | +110.04% |
Promis Neurosciences Inc Stock (PMN) Price Forecast for 2026
The predicted value for Promis Neurosciences Inc (PMN) in 2026 is set at an average of $2.2196. Estimates vary from a peak of $3.2949 to a trough of $1.1444, indicating an +141.26% surge from the present price of $0.92.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $1.6188 | $1.5143 | $2.2758 | +75.96% |
February, 2026 | $1.3837 | $1.3135 | $1.8432 | +50.40% |
March, 2026 | $1.3444 | $1.1444 | $1.6439 | +46.13% |
April, 2026 | $2.1952 | $1.3604 | $3.2949 | +138.61% |
May, 2026 | $2.2758 | $1.6557 | $2.5451 | +147.37% |
June, 2026 | $2.1065 | $2.0013 | $2.3963 | +128.97% |
July, 2026 | $2.1473 | $1.8273 | $2.8072 | +133.40% |
August, 2026 | $2.1102 | $1.5978 | $2.3775 | +129.37% |
September, 2026 | $2.1063 | $2.0059 | $2.6556 | +128.95% |
October, 2026 | $2.0372 | $1.9572 | $2.3399 | +121.43% |
November, 2026 | $1.4281 | $1.3781 | $2.2373 | +55.22% |
December, 2026 | $1.4091 | $1.2091 | $1.7085 | +53.17% |
Promis Neurosciences Inc Stock (PMN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Promis Neurosciences Inc (PMN) is $2.3493, with a high forecast of $3.4248 and a low forecast of $1.2739. This indicates an +155.36% increase from the last price of $0.92.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $2.2713 | $1.4253 | $3.3598 | +146.88% |
February, 2027 | $2.2449 | $1.7209 | $2.3602 | +144.01% |
March, 2027 | $2.172 | $2.0668 | $2.6104 | +136.09% |
April, 2027 | $2.6049 | $2.0124 | $2.8729 | +183.14% |
May, 2027 | $2.1634 | $1.6638 | $2.6631 | +135.16% |
June, 2027 | $2.2402 | $2.0698 | $2.7195 | +143.50% |
July, 2027 | $2.0712 | $2.0306 | $2.4041 | +125.13% |
August, 2027 | $1.6723 | $1.5323 | $2.3016 | +81.77% |
September, 2027 | $1.3537 | $1.3334 | $1.7731 | +47.14% |
October, 2027 | $2.5348 | $1.2739 | $3.4248 | +175.52% |
November, 2027 | $2.3359 | $2.0259 | $2.834 | +153.90% |
December, 2027 | $2.2272 | $1.7861 | $2.6757 | +142.09% |
Promis Neurosciences Inc Stock (PMN) Price Forecast for 2028
In 2028, Promis Neurosciences Inc (PMN) is projected to reach an average price of $2.4142, with a high projection of $3.4897 and a low estimate of $1.3387. This indicates an +162.42% rise from the last price of $0.92.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $2.6783 | $2.0781 | $2.7983 | +191.12% |
February, 2028 | $2.3325 | $1.9589 | $2.9386 | +153.54% |
March, 2028 | $2.3641 | $1.7297 | $2.7835 | +156.97% |
April, 2028 | $2.1612 | $2.0948 | $2.4994 | +134.91% |
May, 2028 | $1.7367 | $1.5967 | $2.366 | +88.78% |
June, 2028 | $1.4956 | $1.3981 | $1.8377 | +62.56% |
July, 2028 | $2.9694 | $1.3387 | $3.411 | +222.76% |
August, 2028 | $2.401 | $2.0197 | $3.4897 | +160.98% |
September, 2028 | $2.4823 | $1.8514 | $2.741 | +169.82% |
October, 2028 | $2.3037 | $2.1437 | $2.5927 | +150.40% |
November, 2028 | $2.3984 | $2.0246 | $3.0043 | +160.70% |
December, 2028 | $2.4574 | $1.7956 | $2.8474 | +167.11% |
Promis Neurosciences Inc Stock (PMN) Price Forecast for 2029
The 2029 price forecast for Promis Neurosciences Inc Stock (PMN) is $2.4791 on average, with a high prediction of $3.5547 and a low estimate of $1.4035. This represents an +169.47% increase from the previous price of $0.92.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $2.2254 | $2.1589 | $2.568 | +141.89% |
February, 2029 | $1.8008 | $1.7533 | $2.4303 | +95.74% |
March, 2029 | $1.6024 | $1.5124 | $1.9512 | +74.17% |
April, 2029 | $1.8479 | $1.4035 | $2.0207 | +100.86% |
May, 2029 | $2.5258 | $1.7844 | $3.5547 | +174.55% |
June, 2029 | $2.5474 | $1.9166 | $2.8063 | +176.89% |
July, 2029 | $2.4389 | $2.2631 | $2.6581 | +165.10% |
August, 2029 | $2.4408 | $2.0904 | $3.07 | +165.31% |
September, 2029 | $2.5008 | $1.8616 | $2.6108 | +171.83% |
October, 2029 | $2.253 | $2.223 | $2.9113 | +144.89% |
November, 2029 | $1.9406 | $1.8361 | $2.5967 | +110.93% |
December, 2029 | $1.7065 | $1.6361 | $2.1652 | +85.49% |
Promis Neurosciences Inc Stock (PMN) Price Forecast for 2030
Promis Neurosciences Inc Stock (PMN) is expected to reach an average price of $2.5764 in 2030, with a high forecast of $3.6846 and a low forecast of $1.4683. This signifies an +180.05% surge from the last price of $0.92.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $1.9127 | $1.4683 | $2.0855 | +107.91% |
February, 2030 | $2.5205 | $1.8493 | $3.6196 | +173.97% |
March, 2030 | $2.6022 | $1.9818 | $2.8715 | +182.85% |
April, 2030 | $2.434 | $2.3286 | $2.7236 | +164.57% |
May, 2030 | $2.4762 | $2.1562 | $3.1358 | +169.15% |
June, 2030 | $2.4292 | $1.9275 | $2.7066 | +164.04% |
July, 2030 | $2.4267 | $2.3252 | $2.9752 | +163.77% |
August, 2030 | $2.3586 | $2.2786 | $2.6609 | +156.37% |
September, 2030 | $1.7506 | $1.7006 | $2.559 | +90.28% |
October, 2030 | $1.7331 | $1.5331 | $2.0316 | +88.38% |
November, 2030 | $2.5964 | $1.7495 | $3.6846 | +182.21% |
December, 2030 | $2.571 | $2.047 | $2.6856 | +179.46% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):